Company’s 36-month beta value is 0.66.Analysts have differing opinions on the stock, with 11 analysts rating it as a “buy,” 1 as “overweight,” 9 as “hold,” and 0 as “sell.”
The public float for PFE is 5.66B, and currently, short sellers hold a 0.98% ratio of that floaft. The average trading volume of PFE on July 26, 2024 was 36.91M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
PFE) stock’s latest price update
Pfizer Inc. (NYSE: PFE)’s stock price has gone rise by 1.76 in comparison to its previous close of 30.18, however, the company has experienced a 2.47% increase in its stock price over the last five trading days. zacks.com reported 2024-07-26 that Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock’s prospects.
PFE’s Market Performance
PFE’s stock has risen by 2.47% in the past week, with a monthly rise of 12.00% and a quarterly rise of 21.58%. The volatility ratio for the week is 2.20% while the volatility levels for the last 30 days are 2.20% for Pfizer Inc. The simple moving average for the past 20 days is 6.50% for PFE’s stock, with a 8.04% simple moving average for the past 200 days.
Analysts’ Opinion of PFE
Guggenheim, on the other hand, stated in their research note that they expect to see PFE reach a price target of $36. The rating they have provided for PFE stocks is “Buy” according to the report published on February 23rd, 2024.
TD Cowen gave a rating of “Market Perform” to PFE, setting the target price at $32 in the report published on January 04th of the current year.
PFE Trading at 7.60% from the 50-Day Moving Average
After a stumble in the market that brought PFE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -17.77% of loss for the given period.
Volatility was left at 2.20%, however, over the last 30 days, the volatility rate increased by 2.20%, as shares surge +9.41% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +7.17% upper at present.
During the last 5 trading sessions, PFE rose by +1.48%, which changed the moving average for the period of 200-days by -8.39% in comparison to the 20-day moving average, which settled at $28.97. In addition, Pfizer Inc. saw 6.67% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PFE starting from Gottlieb Scott, who purchase 3,000 shares at the price of $26.47 back on Dec 15 ’23. After this action, Gottlieb Scott now owns 9,000 shares of Pfizer Inc., valued at $79,401 using the latest closing price.
Stock Fundamentals for PFE
Current profitability levels for the company are sitting at:
- 0.03 for the present operating margin
- 0.49 for the gross margin
The net margin for Pfizer Inc. stands at -0.01. The total capital return value is set at 0.01. Equity return is now at value -0.30, with -0.14 for asset returns.
Based on Pfizer Inc. (PFE), the company’s capital structure generated 0.43 points at debt to capital in total, while cash flow to debt ratio is standing at 0.12. The debt to equity ratio resting at 0.75. The interest coverage ratio of the stock is 0.66.
Currently, EBITDA for the company is 10.53 billion with net debt to EBITDA at 8.27. When we switch over and look at the enterprise to sales, we see a ratio of 4.4. The receivables turnover for the company is 5.01for trailing twelve months and the total asset turnover is 0.25. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.05.
Conclusion
In a nutshell, Pfizer Inc. (PFE) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
